Liver Function Tests and Risk Prediction of Incident Type 2 Diabetes: Evaluation in Two Independent Cohorts

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Abbasi, Ali ^a,b   Bakker, Stephan J L ^a   Corpeleijn, Eva ^a   van der A, Daphne L ^c   Gansevoort, Ron T ^a   Gans, Rijk O B ^a   Peelen, Linda M ^b   van der Schouw, Yvonne T ^b   Stolk, Ronald P ^a   Navis, Gerjan ^a   Spijkerman, Annemieke M W ^c   Beulens, Joline W J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTION; RISK FACTOR; SEX DIFFERENCE; SMOKING;

CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 84871301057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051496     Document Type: Article

References (34)

1. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, et al. (2004) Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 53: 2623-2632.
2. Nakanishi N, Suzuki K, Tatara K, (2004) Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27: 1427-1432.
3. Wannamethee SG, Shaper AG, Lennon L, Whincup PH, (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28: 2913-2918.
4. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, et al. (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 32: 741-750.
5. Schulze MB, Weikert C, Pischon T, Bergmann MM, Al-Hasani H, et al. (2009) Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care 32: 2116-2119.
6. Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, et al. (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31: 2056-2061.
7. Wannamethee SG, Papacosta O, Whincup PH, Thomas MC, Carson C, et al. (2011) The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women. Diabet Med 28: 23-30.
8. Ghouri N, Preiss D, Sattar N, (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 52: 1156-1161.
9. McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY, (2008) Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med 168: 2304-2310.
10. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, et al. (2009) Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119: 2408-2416.
11. Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, de Jong PE, et al. (2012) External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study. Eur J Epidemiol.
12. Rathmann W, Kowall B, Heier M, Herder C, Holle R, et al. (2010) Prediction models for incident type 2 diabetes mellitusin the older population: KORA S4/F4 cohort study. Diabet Med 27: 1116-1123.
13. Buijsse B, Simmons RK, Griffin SJ, Schulze MB, (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33: 46-62.
14. Beulens JW, Monninkhof EM, Verschuren WM, van der Schouw YT, Smit J, et al. (2010) Cohort profile: the EPIC-NL study. Int J Epidemiol 39: 1170-1178.
15. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, et al. (2008) Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168: 897-905.
16. Volovics A, Van Brandt PAD, (1997) Methods for the Analyses of Case-Cohort Studies. Biometrical Journal 39: 195-214.
17. Sluijs I, van der AD, Beulens JW, Spijkerman AM, Ros MM, et al. (2010) Ascertainment and verification of diabetes in the EPIC-NL study. Neth J Med 68: 333-339.
18. Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, et al. (2011) Plasma procalcitonin and risk of type 2 diabetes in the general population. Diabetologia 54: 2463-2465.
19. Volovics A vdBP, (1997) Methods for the Analyses of Case-Cohort Studies. Biom J 39: 195-214.
20. Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, et al. (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 345: e5900.
21. van Houwelingen HC, (2000) Validation, calibration, revision and combination of prognostic survival models. Stat Med 19: 3401-3415.
22. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, et al. (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21: 128-138.
23. Cook NR, Ridker PM, (2009) Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 150: 795-802.
24. Paynter NP, Mazer NA, Pradhan AD, Gaziano JM, Ridker PM, et al. (2011) Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med 171: 1712-1718.
25. Herder C, Baumert J, Zierer A, Roden M, Meisinger C, et al. (2011) Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One 6: e19852.
26. Shafizadeh TB, Moler EJ, Kolberg JA, Nguyen UT, Hansen T, et al. (2011) Comparison of accuracy of diabetes risk score and components of the metabolic syndrome in assessing risk of incident type 2 diabetes in Inter99 cohort. PLoS One 6: e22863.
27. Donders AR, van der Heijden GJ, Stijnen T, Moons KG, (2006) Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59: 1087-1091.
28. Moons KG, (2010) Criteria for scientific evaluation of novel markers: a perspective. Clin Chem 56: 537-541.
29. Chao C, Song Y, Cook N, Tseng CH, Manson JE, et al. (2010) The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 170: 1557-1565.
30. Ding EL, Song Y, Malik VS, Liu S, (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Jama 295: 1288-1299.
31. Association AD, (2011) Standards of medical care in diabetes-2011. Diabetes Care 34Suppl 1: S11-61.
32. Herder C, Karakas M, Koenig W, (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90: 52-66.
33. Vergouwe Y, Moons KG, Steyerberg EW, (2010) External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients. Am J Epidemiol 172: 971-980.
34. Abbasi A, Corpeleijn E, Meijer E, Postmus D, Gansevoort RT, et al. (2012) Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia 55: 1963-70.